Document is current
Any future updates will be listed below
-
Authors
Borelli, Wyllians Vendramini https://orcid.org/0000-0001-9282-0601
Ferreira, Pamela C. L. https://orcid.org/0000-0003-2134-9829
Brum, Wagner S.
Ferrari-Souza, João Pedro https://orcid.org/0000-0003-2183-1551
Carello-Collar, Giovanna
Holz, Maila
Tizeli, Victoria
Strelow, Matheus Zschornack
Formoso, Carolina
Chaves, Marcia Lorena Fagundes
Rocha, Andreia
Aguzzoli, Cristiano Schaffer https://orcid.org/0000-0002-7378-3830
Rohden, Francieli
Souza, Débora G.
Schumacher Schuh, Artur Francisco
Povala, Guilherme
Bellaver, Bruna https://orcid.org/0000-0002-2212-3373
Rosa-Neto, Pedro https://orcid.org/0000-0001-9116-1376
Castilhos, Raphael Machado
Pascoal, Tharick A. https://orcid.org/0000-0001-9057-8014
Zimmer, Eduardo R. https://orcid.org/0000-0002-5349-0053
- License Information
-
More Information
Article History
Received: 25 October 2024
Revised: 15 July 2025
Accepted: 19 August 2025
First Online: 8 September 2025
Competing interests
: WVB has served in the scientific advisory board of masima, and he is also a co-founder and a minority shareholder at masima. ERZ has served on the scientific advisory board, as a consultant or speaker for Nintx, Novo Nordisk, Biogen, Lilly, Magdalena Biosciences and masima. He is also a co-founder and a minority shareholder at masima.
